| Novel approaches to the treatment of thrombosis Trends in Pharmacological Sciences, Volume 23, Issue 1, 1 January 2002, Pages 25-32 Paolo Gresele and Giancarlo Agnelli Abstract Novel approaches to the treatment of thromboembolism include new antagonists of platelet surface receptors, nitric-oxide-releasing antiplatelet agents or inhibitors of crucial steps of the clotting cascade. The latest developments on these drugs classes are presented. Abstract | Full Text | PDF (62 kb) |
| Restenosis: a challenge for pharmacology Trends in Pharmacological Sciences, Volume 21, Issue 7, 1 July 2000, Pages 274-279 Hidde Bult Abstract The quest for an anti-restenotic drug continues to be a major challenge in the field of cardiovascular pharmacology because most therapies with proven efficacy in experimental neointima models have failed to limit restenosis. Some drug classes, including glycoprotein IIb/IIIa antagonists, nitric oxide donors and the antioxidant probucol, have recently demonstrated potential benefits in clinical trials. Progress in the development of local delivery systems for administration of drugs, antisense oligonucleotides or genes, in combination with an improved understanding of the pathogenesis of restenosis holds promise for ultimate pharmacotherapy of this condition. Abstract | Full Text | PDF (111 kb) |
| Oxygen-sensing by ion channels and the regulation of cellular functions Trends in Neurosciences, Volume 19, Issue 10, 1 October 1996, Pages 435-440 José López-Barneo Abstract From bacteria to mammals, ambient O tension influences such diverse cellular functions as gene expression, secretion, contraction and the patterns of electrical activity. Some of the effects of O are attributed to its interaction with various classes of voltage-dependent ion channels. In glomus cells of the carotid body, the differential properties of O-sensitive K and Ca channels help us to understand the basic features of O chemoreception. Modifications of ion-channel activity in response to changes in the partial pressure of O are also involved in the adjustments of vascular tone to hypoxia as well as in the response of chemoreceptors in pulmonary airways. Direct O-sensing by ion channels might also help to explain the alterations of brain function by low O tension. The O-sensitivity of ion-channel activity appears to be a broadly distributed phenomenon contributing to a wide variety of cellular responses to hypoxia. . (1996) 19, 435–440 Abstract | Full Text | PDF (1491 kb) |
Copyright © 1996 The Biophysical Society. All rights reserved.
Biophysical Journal, Volume 70, Issue 3, 1553-1559, 1 March 1996
doi:10.1016/S0006-3495(96)79719-9
Research Article
M.A. Lovich and E.R. Edelman
Classical pharmacokinetic descriptions do not adequately predict the dynamic and complex drug deposition patterns that follow some novel delivery techniques, in part because they do not characterize binding within intact tissues in sufficient detail. In this study, the binding site density of all the potential sites, the tissue-average dissociation constant, and the fractional volume in which heparin can distribute in arterial tissues were measured by incubating tissue samples to equilibrium in solutions containing a wide range of drug concentrations. An "equilibrium distribution curve" was constructed by plotting the concentration of drug in each sample against the concentration in the corresponding bulk phase. The above constants were determined by computationally fitting this curve to a model of drug distribution within tissues. The binding site density was measured to be 4.2 microM, 2.5 microM and 2.2 nM in porcine carotid media with intact and denuded endothelium, and adventitia, respectively. The dissociation constant of heparin in these tissues was estimated to be 6.8 microM, 5.0 microM, and 8.1 nM, respectively. The fractional tissue volume of distribution was 0.61, 0.70, and 0.87, respectively. These values are consistent with known properties of the heparin-arterial tissue interaction. Thus, this technique describes the cumulative effects of binding of a compound to all of its potential binding sites, and will be essential to new detailed descriptions of drug distribution.